arginyl-glycyl-aspartic acid has been researched along with Liver Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Froh, M; Rusyn, I; Thurman, RG; Wheeler, MD; Yamashina, S | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Liver Diseases
Article | Year |
---|---|
Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production.
Topics: Adenoviridae; Animals; Cells, Cultured; Cytokines; DNA-Binding Proteins; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; I-kappa B Proteins; Integrins; Interleukin-10; Kupffer Cells; Lipopolysaccharides; Liver Diseases; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Oligopeptides; Oxidants; Rats; Rats, Sprague-Dawley; Receptors, Virus; Receptors, Vitronectin; Recombinant Fusion Proteins; Superoxide Dismutase; Superoxides; Transcription, Genetic; Transfection; Transgenes; Tumor Necrosis Factor-alpha | 2001 |